CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.97 -0.03 (-0.58%)
As of: Aug 21, 2026 · 9:37 AM EDT

CNS Pharmaceuticals (CNSP) Total Debt (2025)

CNS Pharmaceuticals (CNSP) Total Debt (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.29 Bn 78.30 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 65.17 Bn 59.98 Bn 1.37 Bn -
4 Moderna 61.38 Bn 56.24 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 42.18 Bn 37.09 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 30.99 Bn 27.68 Bn 992.69 Mn -
7 BioNTech SE 28.45 Bn 10.05 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.34 Bn
10 CNS Pharmaceuticals 2.64 Mn -4.56 Mn - 300,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 300,000.00